Curated News
By: NewsRamp Editorial Staff
September 18, 2025
LabConnect Appoints Industry Veteran Bill Finger as SVP of Global Strategic Services
TLDR
- LabConnect gains competitive advantage by appointing Bill Finger as SVP to enhance global strategic services with his 25+ years of diagnostics expertise.
- Bill Finger will lead Scientific Services, Consulting, Data Management, and FSP teams to drive operational excellence and strategy execution at LabConnect.
- This appointment strengthens LabConnect's ability to support complex medical studies, advancing treatments for rare diseases and improving global healthcare outcomes.
- Bill Finger brings extensive experience from Quest Diagnostics and LabCorp to innovate central laboratory services for cutting-edge therapies at LabConnect.
Impact - Why it Matters
This appointment matters because LabConnect plays a critical role in supporting complex clinical trials for groundbreaking treatments including immuno-oncology, cell and gene therapies, and rare diseases. The hiring of an experienced executive like Bill Finger signals the company's commitment to enhancing its capabilities in an increasingly complex clinical research landscape. For patients awaiting new treatments and for pharmaceutical companies developing innovative therapies, strong laboratory partners like LabConnect are essential for ensuring accurate data collection, regulatory compliance, and ultimately, bringing safe and effective treatments to market faster. Finger's extensive background with major diagnostic companies suggests LabConnect is positioning itself to handle the growing complexity of modern clinical trials, which could accelerate the development of life-saving therapies.
Summary
LabConnect, a leading provider of central laboratory services for complex clinical studies, has appointed Bill Finger as Senior Vice President of Global Strategic Services effective September 10, 2025. Finger brings over 25 years of diagnostics and clinical research experience, with deep expertise in the global lab and pharmacy industry. His impressive background includes previous roles as Vice President and General Manager of Pharma Services at Quest Diagnostics, Chief Operating Officer for Interpace Pharma Solutions, and Executive Vice President of Precision Medicine and Pharma for Cancer Genetics, along with leadership positions at LabCorp.
In his new role at LabConnect, Finger will lead the company's Scientific Services, Consulting Services, Data Management, and Functional Service Provider (FSP) teams. LabConnect CEO Wes Wheeler praised the appointment, stating that Finger's leadership in diagnostic and clinical research represents a tremendous asset to the company. Wheeler emphasized that Finger's extensive experience will help LabConnect continue to anticipate client needs, deliver innovative solutions, and reinforce the company's commitment to operational excellence for clients worldwide. The appointment strengthens LabConnect's position as a comprehensive provider for central laboratory service needs in complex study areas including immuno-oncology, cell and gene therapies, and rare diseases.
For more information about LabConnect and its services, interested parties can visit www.LabConnect.com or follow the company on LinkedIn. This strategic hire underscores LabConnect's commitment to maintaining its leadership position in providing state-of-the-art technology, world-class laboratories, and specialized testing expertise to drug development companies operating in major and emerging markets globally.
Source Statement
This curated news summary relied on content disributed by citybiz. Read the original source here, LabConnect Appoints Industry Veteran Bill Finger as SVP of Global Strategic Services
